Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?

Go back to Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?
Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

Pfizer Inc. (NYSE: PFE) Delayed: 28.05 -0.19 (0.67%)
Previous Close $28.24    52 Week High $37.39 
Open $28.00    52 Week Low $28.25 
Day High $28.16    P/E 17.00 
Day Low $27.65    EPS $1.65 
Volume 15,238,737       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 37.11 -0.36 (0.96%)
Previous Close $37.47    52 Week High $66.55 
Open $37.12    52 Week Low $37.82 
Day High $37.35    P/E N/A 
Day Low $36.83    EPS $0.00 
Volume 1,562,794       

Watson Pharmaceuticals, Inc. (NYSE: WPI) Delayed: 85.73 --0 (-0%)
Previous Close $85.73    52 Week High $91.47 
Open $16.30    52 Week Low $57.16 
Day High $85.73    P/E 66.46 
Day Low $85.73    EPS $1.29 
Volume 3,625